Quick Take
Invitae (NVTA) announced it has agreed to acquire Jungla for up to $65 million.
Jungla has developed an Artificial Intelligence-based [AI-based] cloud genetic and genomic tests analysis platform.
NVTA acquired Jungla to bring its machine learning system in-house to improve its genetic test information for patients and health professionals.
Target Company
San Francisco, California-based Jungla was founded in 2016 to help physicians and patients better understand the results of genetic and genomic tests through its cloud-based Functional Modeling Platform that combines clinical findings with advances in functional genomics, biophysics, cellular engineering,